持田製薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2023/09/29 | 3,365 | 3,370 | 3,320 | 3,335 | -30 | -0.9% | 26,800 |
| 2023/09/28 | 3,380 | 3,400 | 3,345 | 3,365 | -90 | -2.6% | 29,300 |
| 2023/09/27 | 3,370 | 3,455 | 3,360 | 3,455 | +80 | +2.4% | 46,300 |
| 2023/09/26 | 3,375 | 3,410 | 3,360 | 3,375 | -30 | -0.9% | 23,600 |
| 2023/09/25 | 3,355 | 3,425 | 3,355 | 3,405 | +50 | +1.5% | 32,300 |
| 2023/09/22 | 3,355 | 3,370 | 3,345 | 3,355 | -30 | -0.9% | 24,700 |
| 2023/09/21 | 3,400 | 3,430 | 3,380 | 3,385 | -10 | -0.3% | 21,100 |
| 2023/09/20 | 3,435 | 3,440 | 3,385 | 3,395 | -40 | -1.2% | 31,500 |
| 2023/09/19 | 3,420 | 3,445 | 3,410 | 3,435 | -5 | -0.1% | 25,500 |
| 2023/09/15 | 3,415 | 3,465 | 3,390 | 3,440 | +25 | +0.7% | 66,800 |
| 2023/09/14 | 3,390 | 3,425 | 3,375 | 3,415 | +10 | +0.3% | 22,400 |
| 2023/09/13 | 3,395 | 3,410 | 3,360 | 3,405 | +20 | +0.6% | 34,000 |
| 2023/09/12 | 3,340 | 3,395 | 3,340 | 3,385 | +55 | +1.7% | 27,300 |
| 2023/09/11 | 3,330 | 3,345 | 3,295 | 3,330 | +20 | +0.6% | 35,600 |
| 2023/09/08 | 3,350 | 3,370 | 3,310 | 3,310 | -70 | -2.1% | 47,800 |
| 2023/09/07 | 3,410 | 3,410 | 3,370 | 3,380 | -30 | -0.9% | 27,400 |
| 2023/09/06 | 3,415 | 3,430 | 3,395 | 3,410 | -5 | -0.1% | 21,200 |
| 2023/09/05 | 3,385 | 3,420 | 3,375 | 3,415 | +20 | +0.6% | 28,300 |
| 2023/09/04 | 3,425 | 3,425 | 3,385 | 3,395 | -20 | -0.6% | 24,100 |
| 2023/09/01 | 3,375 | 3,425 | 3,375 | 3,415 | +40 | +1.2% | 35,500 |
| 2023/08/31 | 3,375 | 3,390 | 3,370 | 3,375 | +15 | +0.4% | 39,600 |
| 2023/08/30 | 3,365 | 3,380 | 3,345 | 3,360 | +20 | +0.6% | 27,800 |
| 2023/08/29 | 3,345 | 3,365 | 3,325 | 3,340 | -5 | -0.1% | 26,400 |
| 2023/08/28 | 3,320 | 3,360 | 3,320 | 3,345 | +30 | +0.9% | 30,000 |
| 2023/08/25 | 3,300 | 3,340 | 3,300 | 3,315 | -5 | -0.2% | 29,200 |
| 2023/08/24 | 3,290 | 3,335 | 3,290 | 3,320 | +30 | +0.9% | 16,200 |
| 2023/08/23 | 3,260 | 3,295 | 3,260 | 3,290 | -10 | -0.3% | 11,700 |
| 2023/08/22 | 3,290 | 3,305 | 3,270 | 3,300 | +30 | +0.9% | 20,900 |
| 2023/08/21 | 3,265 | 3,290 | 3,265 | 3,270 | +25 | +0.8% | 20,900 |
| 2023/08/18 | 3,235 | 3,270 | 3,230 | 3,245 | -5 | -0.2% | 24,700 |
| 2023/08/17 | 3,320 | 3,330 | 3,240 | 3,250 | -95 | -2.8% | 30,800 |
| 2023/08/16 | 3,320 | 3,350 | 3,320 | 3,345 | -5 | -0.1% | 17,800 |
| 2023/08/15 | 3,345 | 3,355 | 3,315 | 3,350 | +5 | +0.1% | 19,500 |
| 2023/08/14 | 3,330 | 3,370 | 3,330 | 3,345 | +15 | +0.5% | 28,400 |
| 2023/08/10 | 3,285 | 3,340 | 3,270 | 3,330 | +45 | +1.4% | 35,700 |
| 2023/08/09 | 3,285 | 3,295 | 3,250 | 3,285 | +10 | +0.3% | 29,800 |
| 2023/08/08 | 3,215 | 3,290 | 3,205 | 3,275 | +100 | +3.1% | 46,900 |
| 2023/08/07 | 3,210 | 3,245 | 3,155 | 3,175 | -20 | -0.6% | 65,900 |
| 2023/08/04 | 3,285 | 3,290 | 3,165 | 3,195 | -95 | -2.9% | 59,000 |
| 2023/08/03 | 3,270 | 3,305 | 3,265 | 3,290 | -25 | -0.8% | 45,200 |
| 2023/08/02 | 3,330 | 3,345 | 3,310 | 3,315 | -30 | -0.9% | 33,500 |
| 2023/08/01 | 3,305 | 3,345 | 3,305 | 3,345 | +40 | +1.2% | 25,900 |
| 2023/07/31 | 3,320 | 3,345 | 3,300 | 3,305 | +20 | +0.6% | 51,400 |
| 2023/07/28 | 3,280 | 3,295 | 3,240 | 3,285 | +5 | +0.2% | 38,600 |
| 2023/07/27 | 3,280 | 3,285 | 3,250 | 3,280 | ±0 | ±0% | 18,600 |
| 2023/07/26 | 3,270 | 3,290 | 3,245 | 3,280 | +40 | +1.2% | 38,400 |
| 2023/07/25 | 3,250 | 3,270 | 3,225 | 3,240 | -15 | -0.5% | 24,900 |
| 2023/07/24 | 3,230 | 3,255 | 3,220 | 3,255 | +40 | +1.2% | 18,400 |
| 2023/07/21 | 3,210 | 3,225 | 3,190 | 3,215 | +25 | +0.8% | 17,500 |
| 2023/07/20 | 3,235 | 3,235 | 3,190 | 3,190 | -35 | -1.1% | 15,800 |
401～
450
件表示中 / 3705件
類似銘柄と比較する
現在ご覧いただいている「持田薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 持田薬 | 297,600円 | +5.1% | -7.0% | 2.69% | 19.54倍 | 0.81倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
| ジーエヌアイ | 297,100円 | +21.7% | +999.9% | 0.00% | 12.45倍 | 4.12倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
| ゼリア新薬 | 213,700円 | +3.1% | -6.5% | 2.25% | 9.92倍 | 1.05倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
| 杏林製薬 | 146,000円 | -2.4% | -52.3% | 3.90% | 17.47倍 | 0.62倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
| 栄研化 | 200,000円 | +4.1% | -3.1% | 2.90% | 17.54倍 | 1.53倍 |
|
臨床検査薬大手。便潜血検査試薬（ＦＩＴ）はシェア７割。尿検査（ウロ）、遺伝子検査も育成 |
市場注目の銘柄
チャート関連のコラム
